Dupen Laboratories Profile
Key Indicators
- Authorised Capital ₹ 5.00 M
- Paid Up Capital ₹ 0.99 M
- Company Age 48 Year, 11 Months
- Last Filing with ROC 31 Mar 2023
- Satisfied Charges ₹ 3.19 Cr
- Revenue Growth -68.65%
- Profit Growth -147.47%
- Ebitda -241.69%
- Net Worth -76.41%
- Total Assets -58.31%
About Dupen Laboratories
Dupen Laboratories Private Limited (DLPL) is a leading Private Limited Indian Non-Government Company incorporated in India on 23 March 1976 and has a history of 48 years and 11 months. Its registered office is in Mumbai, Maharashtra, India.
The Corporate was formerly known as Rama Pharma Lab Pvt Ltd. The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 5.00 M and a paid-up capital of Rs 0.99 M.
The company has closed loans amounting to ₹3.19 Cr, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
Rajeshwari Datla, Anupama Desai, and Nagendra Nadimpally serve as directors at the Company.
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U24239MH1976PTC103955
- Company No.
103955
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
23 Mar 1976
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Who are the key members and board of directors at Dupen Laboratories?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Rajeshwari Datla  | Managing Director | 01-Jan-1995 | Current |
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Anupama Desai | Director | 15-Dec-2004 | Current |
| Nagendra Nadimpally | Whole-Time Director | 01-Jan-2017 | Current |
Financial Performance of Dupen Laboratories.
Dupen Laboratories Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 68.65% decrease. The company also saw a substantial fall in profitability, with a 147.47% decrease in profit. The company's net worth observed a substantial decline by a decrease of 76.41%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Dupen Laboratories?
Unlock access to Dupen Laboratories's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Fermenta Biotech LimitedRajeshwari Datla and Anupama Desai are mutual person
Lacto-Cosmetics (Vapi) Private LimitedRajeshwari Datla, Anupama Desai and 1 more are mutual person
Charges (Loans)
₹0
₹31.87 M
Charges Breakdown by Lending Institutions
- Corporation Bank : 2.55 Cr
- Bank Of Baroda : 0.60 Cr
- Gujarat State Financial Corporation : 0.04 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 11 Nov 2009 | Corporation Bank | ₹2.55 Cr | Satisfied |
| 05 Nov 1993 | Bank Of Baroda | ₹3.70 M | Satisfied |
| 28 Mar 1992 | Bank Of Baroda | ₹0.90 M | Satisfied |
| 19 Jul 1990 | Bank Of Baroda | ₹1.02 M | Satisfied |
| 30 Jan 1986 | Bank Of Baroda | ₹0.20 M | Satisfied |
How Many Employees Work at Dupen Laboratories?
Dupen Laboratories has a workforce of 6 employees as of Aug 26, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Dupen Laboratories, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Dupen Laboratories's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
